TAE - Overview: Therapeutic Antibody by Flow Cytometry

Test Catalog

Test Name

Test ID: TAE    
Therapeutic Antibody by Flow Cytometry

Useful For Suggests clinical disorders or settings where the test may be helpful

Detecting cell-surface antigens on malignant cells that are potential therapeutic antibody targets


Determining the eligibility of patients for monoclonal antibody therapies


Monitoring response to the therapeutic antibody

Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests

Test IDReporting NameAvailable SeparatelyAlways Performed
FIRSTFlow Cytometry, Cell Surface, FirstNo, (Bill Only)No
ADD1Flow Cytometry, Cell Surface, AddlNo, (Bill Only)No
FCINTFlow Cytometry Interp, 2-8 MarkersNo, (Bill Only)No
FCIMSFlow Cytometry Interp, 9-15 MarkersNo, (Bill Only)No
FCINSFlow Cytometry Interp,16 or greaterNo, (Bill Only)No

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

When a blood or bone marrow is ordered, a panel specific to the desired antibody and a professional interpretation will always be charged. The panel will be charged based on number of markers tested (FIRST for first marker, ADD1 for each additional marker). The interpretation will be based on the 2 to 8 markers tested.

Method Name A short description of the method used to perform the test


NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

Therapeutic Antibody Evaluation

Aliases Lists additional common names for a test, as an aid in searching

Alemtuzumab (Campath) (CD52)
Campath-1H (CD52)
Ibritumomab Tiuxetin (Zevalin) (CD20)
Rituximab (Rituxan) (CD20)
Tositumomab (Bexxar) (CD20)